Resveratrol (RES) is a potential candidate to help prevent bone-related complications in children during and after chemotherapy, a study carried out by Australian and Chinese academics claims.

RES is suggested to be a potential candidate for the development of preventative strategies to prevent the bone-related complications during and/or after MTX chemotherapy. Further studies are required to investigate its optimal dosage and its action mechanisms in protecting bone during cancer chemotherapy, including using cancer-bearing models.